Stereotactic MR-guided on-table adaptive radiation therapy (SMART) for borderline resectable and locally advanced pancreatic cancer: A multi-center, open-label phase 2 study

Authors

Michael D Chuong, Baptist Health South Florida
Hyun Kim, Washington University School of Medicine in St. Louis
Lauren E Henke, Washington University School of Medicine in St. Louis
Alex T Price, Washington University School of Medicine in St. Louis
et al.

Journal

Radiotherapy and oncology

Publication Date

2-1-2024

Volume

191

First Page

110064

Document Type

Open Access Publication

DOI

10.1016/j.radonc.2023.110064

Rights and Permissions

Chuong MD, Lee P, Low DA, Kim J, Mittauer KE, Bassetti MF, Glide-Hurst CK, Raldow AC, Yang Y, Portelance L, Padgett KR, Zaki B, Zhang R, Kim H, Henke LE, Price AT, Mancias JD, Williams CL, Ng J, Pennell R, Raphael Pfeffer M, Levin D, Mueller AC, Mooney KE, Kelly P, Shah AP, Boldrini L, Placidi L, Fuss M, Jitendra Parikh P. Stereotactic MR-guided on-table adaptive radiation therapy (SMART) for borderline resectable and locally advanced pancreatic cancer: A multi-center, open-label phase 2 study. Radiother Oncol. 2024 Feb;191:110064. doi: 10.1016/j.radonc.2023.110064. © 2023 The Author(s). Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/bync-nd/4.0/).

Recommended Citation

Chuong, Michael D; Kim, Hyun; Henke, Lauren E; Price, Alex T; and et al., "Stereotactic MR-guided on-table adaptive radiation therapy (SMART) for borderline resectable and locally advanced pancreatic cancer: A multi-center, open-label phase 2 study." Radiotherapy and oncology. 191, 110064 (2024).
https://digitalcommons.wustl.edu/oa_4/3733

Additional Links

Supplemental material is available for this article at publisher site.